# Performa Ltd (US), LLC

> Institutional holdings reported to the SEC as of Q2 2026 on Form 13F. CIK 1650303. Source: https://holderbook.com/funds/1650303-performa-ltd-us-llc/

- Reported value: $619.7M
- Positions: 49
- Weight of the ten largest: 92.9%
- Filed: 2026-08-03

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| VANGUARD INDEX FDS | [VOO](https://holderbook.com/stocks/VOO/) | $137.2M | 199,789 | 22.1% | 21 |
| ISHARES TR | [IWR](https://holderbook.com/stocks/IWR/) | $124.0M | 1,124,020 | 20.0% | 12 |
| VANGUARD INDEX FDS | [VO](https://holderbook.com/stocks/VO/) | $75.8M | 940,415 | 12.2% | 21 |
| STATE STR SPDR S&amp;P 500 ETF T | [SPY](https://holderbook.com/stocks/SPY/) | $71.9M | 96,297 | 11.6% | 31 |
| DBX ETF TR | [HYLB](https://holderbook.com/stocks/HYLB/) | $58.7M | 1,608,678 | 9.5% | 21 |
| VANGUARD INTL EQUITY INDEX F | [VEU](https://holderbook.com/stocks/VEU/) | $44.7M | 533,277 | 7.2% | 27 |
| VANGUARD INDEX FDS | [VBR](https://holderbook.com/stocks/VBR/) | $27.0M | 111,091 | 4.4% | 13 |
| INVESCO EXCHANGE TRADED FD T | [RSP](https://holderbook.com/stocks/RSP/) | $15.3M | 72,043 | 2.5% | 2 |
| VANGUARD INDEX FDS | [VBK](https://holderbook.com/stocks/VBK/) | $11.6M | 31,759 | 1.9% | 26 |
| ISHARES TR | [IJR](https://holderbook.com/stocks/IJR/) | $9.4M | 63,258 | 1.5% | 21 |
| INVESCO EXCHANGE TRADED FD T | [SPHQ](https://holderbook.com/stocks/SPHQ/) | $8.7M | 96,887 | 1.4% | 20 |
| ISHARES TR | [QUAL](https://holderbook.com/stocks/QUAL/) | $8.6M | 39,117 | 1.4% | 20 |
| INVESCO QQQ TR | [QQQ](https://holderbook.com/stocks/QQQ/) | $5.9M | 8,000 | 1.0% | 1 |
| ISHARES INC | [EWJ](https://holderbook.com/stocks/EWJ/) | $3.8M | 40,531 | 0.6% | 22 |
| SPDR SERIES TRUST | [XSW](https://holderbook.com/stocks/XSW/) | $3.8M | 22,000 | 0.6% | 2 |
| VANECK ETF TRUST | [ANGL](https://holderbook.com/stocks/ANGL/) | $3.6M | 123,913 | 0.6% | 21 |
| VANGUARD INDEX FDS | [VTI](https://holderbook.com/stocks/VTI/) | $3.0M | 8,000 | 0.5% | 1 |
| ISHARES TR | [IWN](https://holderbook.com/stocks/IWN/) | $2.5M | 11,084 | 0.4% | 31 |
| SPDR SERIES TRUST | [SDY](https://holderbook.com/stocks/SDY/) | $1.4M | 9,455 | 0.2% | 1 |
| ISHARES TR | [IWV](https://holderbook.com/stocks/IWV/) | $1.1M | 2,500 | 0.2% | 1 |
| ISHARES TR | [IWP](https://holderbook.com/stocks/IWP/) | $654.2K | 4,468 | 0.1% | 24 |
| LESLIES INC | [LESL](https://holderbook.com/stocks/LESL/) | $585.7K | 57,700 | 0.1% | 4 |
| OATLY GROUP AB | [OTLY](https://holderbook.com/stocks/OTLY/) | $106.6K | 11,400 | 0.0% | 4 |
| ADOBE INC | [ADBE](https://holderbook.com/stocks/ADBE/) | $56.4K | 275 | 0.0% | 4 |
| ASANA INC | [ASAN](https://holderbook.com/stocks/ASAN/) | $47.4K | 6,775 | 0.0% | 19 |
| ZOOMINFO TECHNOLOGIES INC | [GTM](https://holderbook.com/stocks/GTM/) | $46.9K | 16,000 | 0.0% | 14 |
| SHUTTERSTOCK INC | [SSTK](https://holderbook.com/stocks/SSTK/) | $44.0K | 3,156 | 0.0% | 6 |
| DENTSPLY SIRONA INC | [XRAY](https://holderbook.com/stocks/XRAY/) | $32.9K | 3,100 | 0.0% | 9 |
| BLACKBAUD INC | [BLKB](https://holderbook.com/stocks/BLKB/) | $25.9K | 875 | 0.0% | 4 |
| DOCUSIGN INC | [DOCU](https://holderbook.com/stocks/DOCU/) | $22.2K | 500 | 0.0% | 2 |
| MARAVAI LIFESCIENCES HLDGS I | [MRVI](https://holderbook.com/stocks/MRVI/) | $12.5K | 2,000 | 0.0% | 17 |
| PEDIATRIX MEDICAL GROUP INC | [MD](https://holderbook.com/stocks/MD/) | $11.8K | 467 | 0.0% | 23 |
| PAYSAFE LIMITED | [PSFE](https://holderbook.com/stocks/PSFE/) | $11.6K | 1,550 | 0.0% | 5 |
| EXXON MOBIL CORP | [XOMXXXX](https://holderbook.com/stocks/XOMXXXX/) | $10.3K | 75 | 0.0% | 23 |
| PAYPAL HLDGS INC | [PYPL](https://holderbook.com/stocks/PYPL/) | $7.4K | 171 | 0.0% | 6 |
| TILRAY BRANDS INC | [TLRY](https://holderbook.com/stocks/TLRY/) | $7.2K | 1,600 | 0.0% | 1 |
| VAREX IMAGING CORP | [VREX](https://holderbook.com/stocks/VREX/) | $6.3K | 600 | 0.0% | 10 |
| SONOS INC | [SONO](https://holderbook.com/stocks/SONO/) | $6.2K | 459 | 0.0% | 21 |
| ASPEN AEROGELS INC | [ASPN](https://holderbook.com/stocks/ASPN/) | $5.1K | 800 | 0.0% | 1 |
| JELD-WEN HLDG INC | [JELD](https://holderbook.com/stocks/JELD/) | $5.0K | 3,350 | 0.0% | 9 |
| UIPATH INC | [PATH](https://holderbook.com/stocks/PATH/) | $4.9K | 450 | 0.0% | 10 |
| EVERPURE INC | [P](https://holderbook.com/stocks/P/) | $4.7K | 60 | 0.0% | 8 |
| SALLY BEAUTY HLDGS INC COM | - | $4.6K | 325 | 0.0% | 2 |
| GETTY IMAGES HOLDINGS INC | [GETY](https://holderbook.com/stocks/GETY/) | $3.0K | 3,500 | 0.0% | 6 |
| CLARIVATE PLC | [CLVT](https://holderbook.com/stocks/CLVT/) | $2.7K | 1,250 | 0.0% | 6 |
| ORSTED A/S UNSPONSORED ADR | [DNNGY](https://holderbook.com/stocks/DNNGY/) | $2.2K | 300 | 0.0% | 4 |
| ORION S.A. | [OEC](https://holderbook.com/stocks/OEC/) | $1.3K | 201 | 0.0% | 4 |
| RETRACTABLE TECHNOLOGIES INC | [RVP](https://holderbook.com/stocks/RVP/) | $1.3K | 1,750 | 0.0% | 22 |
| VISTAGEN THERAPEUTICS INC | [VTGN](https://holderbook.com/stocks/VTGN/) | $1.2K | 5,500 | 0.0% | 7 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | +12.5% | +14.8% | -2.4% | 100% |
| Q1 2026 | -2.3% | -4.6% | +2.3% | 100% |
| Q4 2025 | +1.3% | +2.4% | -1.1% | 100% |
| Q3 2025 | +6.3% | +7.8% | -1.5% | 100% |
| Q2 2025 | +7.9% | +10.5% | -2.5% | 100% |
| Q1 2025 | -2.6% | -4.6% | +2.0% | 100% |
| Q4 2024 | +0.3% | +2.1% | -1.9% | 100% |
| Q3 2024 | +6.5% | +5.4% | +1.1% | 100% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2026 | $619.7M | 49 |
| Q1 2026 | $442.0M | 47 |
| Q4 2025 | $394.1M | 50 |
| Q3 2025 | $377.1M | 53 |
| Q2 2025 | $331.7M | 51 |
| Q1 2025 | $300.7M | 53 |
| Q4 2024 | $284.1M | 51 |
| Q3 2024 | $269.3M | 52 |
| Q2 2024 | $243.3M | 55 |
| Q1 2024 | $227.3M | 57 |
| Q4 2023 | $230.3M | 51 |
| Q3 2023 | $210.4M | 77 |

